# LockedBrands Smart Lockbox Systems that Make Communities and Households Safer ## Elevator pitch We make communities safer by creating solutions for the opioid and prescription drug abuse problem in this country. - Canonical URL: https://wefunder.com/lockedbrands - Entity ID: wefunder:company:63102 - Last updated: 2026-06-05T05:00:20Z - Generated at: 2026-06-05T20:57:25Z ## Quick facts - A real solution to the opioid and prescription drug abuse epidemic. - Reach a market of over 118M Americans. - In-production Gen 1 generating sales now. - Gen 2 features Software-as-a-Service (SaaS) and compliance data revenue streams. - 33% manufacturing cost reduction since Q2 2019. - Team of senior tech leaders, doctors, entrepreneurs with 120 years combined relevant experience. - IP protection: Utility patents and CIPs filed. - Marketing plan on schedule and showing strong signs of pandemic recovery ## Active fundraises - wefunder:fundraise:36363: 4(a)(6) successful (USD) ## Story Bottom Line:  33,000+ opioid involved overdose deaths and up to $600 billion, annually.  Redefining Secure StorageLockedBrands was founded in 2017 with the goal of creating a solution for the prescription drug abuse and opioid epidemic.The Problem & SolutionIn 2017, the United States Department of Health and Human Services declared a public health emergency due to the opioid crisis. Founder & CEO, Justin Monger, like so many Americans, was directly impacted by the crisis.  One of his siblings suffered from addiction issues her entire adult life.  He saw first hand the devastation to the individual and the family.     The Solution:  LockedBrands was founded in 2017 with the goal of securing opioids, controlled substances, and personal valuables. We initially launched on Kickstarter in late 2018 with The Pillar/StashCan: a portable, voice-activated, app-controlled personal lockbox. The Pillar/StashCan is LockedBrands Gen 1 device.  It is ideal for storing meds and other valuables. The Pillar/StashCan is in production and available online and in-stores.  Our Gen 2 device, the Secure Med Manager (SMM) is in development now.  The SMM not only secures meds, like The Pillar, but also dispenses them only to the patient, and only per the doctor's prescription, and generates a compliance record in the cloud.  Further, if tampered with, it shuts down and notifies the healthcare team via the cloud.  The proof-of-concept prototype, shown above, was completed in April 2020.  Watch this video to see all the capabilities The Pillar has to offer:Watch this StashCan promotional video: Investor Testimonials - Hear What our Investors have to sayDr. Sajad Zalzala, MD -  Wefunder Investor Briand Greer, Seed & Angel round Investor, Strategic Advisor for Asia/f41f93250dBryan Waters, Angel Investor, Board Member & Strategic Advisor/8069b24af5LockedBrands Board Members are Investors as wellThe success of LockedBrands is driven by more than our day-to-day staff.  It really is a team effort that includes our board members and investors. Strategic AdvisorsHow We Are Making it Happen: Our Growth StoryMarket Sizing for the Gen 1 DeviceThe total addressable market for the Gen 1 device, the personal lockbox, is over 60M in the US alone.  Taking into account Europe, Middle East, Asia, Latin America, and Asia Pacific the market sizing could easily triple.Dual Positioning for Better Market PenetrationHaving The Pillar and The StashCan as identical products, but positioned for different market sub-segments, allows us to focus our marketing based on the customer's needs.  The StashCan StoryThe rapidly emerging legal cannabis industry promises significant growth opportunities. Given its added complexities and regulations, we developed a second, standalone brand, StashCan, managed by ArxLabs, aimed at this expanding market. While non-traditional, we believe this dual-positioning and branding of our singular product will maximize growth.MARKET SEGMENT The gadget-oriented/high-tech cannabis segment is estimated at 21M consumers. The StashCan is the leading storage solution for responsible cannabis users-- a smart device that provides access, sharing, logging, and voice-action through voice profiles from Amazon Alexa. The StashCan is also smell proof, delivering added discretion and peace of mind to its users.LEADER IN RESPONSIBLE STORAGEWhether prescription opioids, keys to a gun safe, or cannabis, consumers need a trusted solution for locking away and control access to personal items, particularly in the presence of children and young adults. LockedBrands will establish industry leadership by uniquely positioning Pillar and StashCan at the areas of greatest market need.Market Access To-DateThe StashCan has demonstrated traction since its launch through MasterMinded in February of this year.  We have signed up over 60 authorized StashCan retailers since partnering with MasterMinded.    Pillar sales through retailers is picking up in Q3 with Sharper Image,  community pharmacies, and a specialized Blue Star Senior Tech retailer.  The direct to consumer (DTC) sales channel, which has the best margins, will be the marketing focus with funding from this crowdfunding campaign.  Better than the RestPrice point, coupled with key features like smell-proof, voice activation, and shared access put The Pillar (and StashCan) in a class of its own.  Key advantages include:  Price point; Opens from anywhere; Voice-activation; Logs all access; Access without a key or combination; Smell proof.  For more details on the competition, please see the Investor Deck under Downloads.  The Secure Med ManagerWe have developed a proof-of-concept prototype for the SMM. It demonstrates some of the key functions as listed below.  Be sure to watch the lab demo below as well.  Market Sizing for the Secure Med Manager (SMM)The SMM has a significant total addressable market, (TAM), 58M in the US alone.  As with the Pillar, taking into account Europe, Middle East, Asia, Latin America, and Asia Pacific the market sizing could easily triple.  Further, this sizing is limited to the two use cases above.  Taking into account senior living centers, retirement homes, Alzheimer's facilities and assisted living centers, the potential market grows significantly.  While there are competitors trying to address both use cases described above, there is a very small number trying to address use case #2.  As a result, the SMM for those with chronic pain or opioid misuse disorder is the primary market thrust for the near term.  The secondary market for the SMM, Americans with two or more chronic diseases, will be addressed once the opioid version of the SMM is in low-rate-initial-production (LRIP), Q4 2021. Go To Market for the Secure Med ManagerReimbursement Strategy:  The SMM has multiple value propositions across the entire health care eco-system, including prescription providers, distributors, manufacturer rep firms, health insurance companies, health care providers, senior and assisted living facilities, and home care providers.  We are focused on selecting the right reimbursement strategy for a strategic partner in order to achieve quick market penetration.Distribution & sales channels:  We have a signed letter of intent to support opioid trials in early 2021.  This will provide access to the Veterans Administration as well as provide trial data that will be crucial for the major pharmacy benefit managers (PBMs).  Grants:  We are always seeking non-profit partners for grants and other funding to support the on-going battle of the opioid crisis.  Secure Med Manager PrototypeWe have developed a proof-of-concept prototype for the SMM.  It demonstrates some of the key functions as listed below.  Be sure to watch the lab demo.  /d6ce9e683cCompetitive Landscape for Secure Med ManagerPrimary market - Use Case #2: Americans with chronic pain or opioid misuse disorder. This is the primary market thrust for the SMM in the near term.  The primary competition for the secure storage and dispensing of opioids is the Take-As-Directed (TAD). It dispenses individual pills, as opposed to pill packs, like the SMM.  Therefore, the TAD cannot be used by the large number of patients that take opioids in combination with other controlled substances, eg opioids with anti-depressants. As a result, the market segment addressed by the SMM will not be the same as that addressed by the TAD.  The SMM also has strong tamper detect logic that shuts down the unit and notifies the health care team through the cloud should someone attempt to break into it. Key advantages include:  Price point; Pill pack compatibility enables dispensing more than one controlled substance; Pill packs are very easy for a pharmacy to load;  Anti-tamper provides strong motivation for patients not to tamper with the dispenser.  There is limited competition for the opioid use case.Secondary Market - Use case #1:  Americans with two or more chronic diseasesThe use case for Americans with two or more chronic diseases is currently a secondary market for the SMM.  For more details, please see the Investor Deck in the Downloads section.  How Your Investment Will HelpWhat can we accomplish with the funds?  We anticipate the business going cash positive in 2021 as a result of a significant marketing and sales effort.  Continue the development of the Secure Med Manager (SMM) production prototype with requirements definition and detailed designComplete Beta testing and support FDA trials for one of our strategic partnersSeek alternative funding sources for the SMM through grantsComplete manufacturing cost reduction effort by moving operations out of China and into a friendlier, more cost effective countrySecure Med Manager Development ScheduleIf fully funded, this crowdfunding capital raise will fund the SMM development through Requirements Definition, Detailed Design / FDA Registration and into some amount of LRIP 1 and Beta testing.  The scope of Beta testing, coupled with the exact nature of our relationship with our  strategic partner, will determine what effort will be needed to get into LRIP 2 production.  LRIP 2 production will be followed by a regional roll-out of the SMM product.  LRIP - Low Rate Initial Production ## FAQ 1. **Hi. how much is it per share?** - Kimberly, great question!  But since this is a convertible note, a direct answer is difficult.  Could we schedule a time for a phone call so I can explain?  If so, please propose a few times or use my Calendly link:  calendly.com/justin-lockedbrands 2. **Hi Justin: I am interested have couple of questions. 1. Please explain on revenue generation-how much cost etc. 2. What is the revenue expectation this year and next 5 years. 3. Who is your competitor? IF I do google search 'wifi enable lockbox'; I see lot of them how do you c...** - Mohammad,Thank you for your very good questions.  I will give the short answers here, but would really like to have a call so I can explain everything in complete detail.  Questions 1 and 2 are covered in chart 13 of the Investor deck.  Competitors are listed and compared in chart 18.  The valuation number you mentioned is the Valuation Cap, not the value of the company at this time.  If you go here on the Wefunder site (https://help.wefunder.com/foun...)  a... 3. **I'd be concerned about the practical, on-the-ground application of this technology. I notice that your reviewers are largely (if not solely) male, largely upper-level employees/leaders in the medical industry, and none of them appear to be nurses or social workers who can spea...** - Thank you very much for the question.  I would like to point out that there are two practicing physicians on our advisory board, one male and one female.  Their details are in the investor chart deck in the download section.  That said, we have spoken with hundreds of doctors, RNs, PA's, Pharmacists, Nurse Practitioners and others in the health care industry.  Across the board, there is agreement that the application of this technology to pill regimen compliance could be v... ## Team - Justin Monger (Founder and CEO) - Brian J. Esposito (Enterprise Level Strategic Advisor) - David Lee (Chief Engineer) - Randy Heinrich (Director of Operations) - John Proffer (Software Architect) - Bruce W Nunnally (Fractional CFO) - Aruni Ellepola (CBO & China Trade Regulations Analyst) ## Recent posts - Our Campaign Wrap Up & Great News for Our Investors! (2021-01-27T22:15:57Z) - The Final Week of Our Campaign is Here, Join Our Newsletter to Keep Up With Us! (2021-01-25T17:08:55Z) - CEO and Founder, Justin Monger, Featured in New Business Handbook (2021-01-18T18:23:05Z) - Great News! We Have our First Launch Partner for our Secure Med Manager System! 🤩 (2021-01-07T20:02:35Z) - 👋 Early Bird Terms Ending Soon... We're Almost at $200K Raised! 🤩 (2021-01-05T20:09:01Z) - LockedBrands Pledges to Provide Donations to Invisible Disabilities® Association (2020-12-15T19:03:42Z) - It's Holiday Hibernation Time! (2020-12-11T20:56:16Z) - Incredible Development within the Healthcare Industry: The Rise of Telehealth and Expansion of Care Options (2020-12-07T17:58:08Z) - Black Friday & Cyber Monday Sale is Live! (2020-11-27T21:44:00Z) - Did you miss our live webinar? No worries! Watch it here. (2020-11-23T21:49:26Z) - Facebook Live Webinar: Remote Patient Monitoring and the Secure Med Manager (2020-11-17T20:33:09Z) - A Conversation with Dr. Fatima (2020-11-13T16:27:38Z) - You Can Win a Pillar! (2020-11-12T18:13:02Z) - Great press coverage for LockedBrands in Dallas-area Blue Ribbon News (2020-11-06T18:06:46Z) - New Enterprise Level Strategic Advisor, Dr. Marc O'Griofa (2020-11-04T17:46:50Z) ## Q&A - Q: PERKS - Q: I'd be concerned about the practical, on-the-ground application of this technology. I notice that your reviewers are largely (if not solely) male, largely upper-level employees/leaders in the medical industry, and none of them appear to be nurses or social workers who can speak to the efficacy of a technological device in the face of a very slippery and manipulative public health crisis. Optics would be better to get a feel from the population where the opioid crisis is actually happening. Is that something you're able to do? - A: Thank you very much for the question.  I would like to point out that there are two practicing physicians on our advisory board, one male and one female.  Their details are in the investor chart deck in the download section.  That said, we have spoken with hundreds of doctors, RNs, PA's, Pharmacists, Nurse Practitioners and others in the health care industry.  Across the board, there is agreement that the application of this technology to pill regimen compliance could be very effective and is long overdue.  Further, after these conversations, it became clear that there will have to be a somewhat unique instantiation of the Secure Med Manager based on the use case and the unique characteristics of the patient population.  For example, the requirements of the SMM for a first time opioid user would be different from what is needed for the patient with opioid misuse disorder or a patient with chronic pain & PTSD, or a patient with two or more chronic diseases that has a complex pill regimen.  Thus, we have ongoing discussions with pharmacists, doctors, pain management centers, and the entire realm of health care professionals in order to develop the most effective SMM for the target patient population.  So, I can say that these conversations are something that we have been doing and are continuing to do.  However, the results of these conversations is the detailed and proprietary strategy for our particular market segment(s) and will not be posted for competitor consumption.  I would welcome the opportunity to discuss this topic further with you... one can never have too much insight into this public health crisis.  Could we schedule a quick 15 minute call so I can get insights and answer any further questions you may have?  My calendly link is: calendly.com/justin-lockedbrands - Q: Hi Justin: I am interested have couple of questions. 1. Please explain on revenue generation-how much cost etc. 2. What is the revenue expectation this year and next 5 years. 3. Who is your competitor? IF I do google search 'wifi enable lockbox'; I see lot of them how do you compete with them or let's say they started making similar on as your one. 4. how do you get valuation 7M at this stage of the business. Please explain. - A: Mohammad,Thank you for your very good questions.  I will give the short answers here, but would really like to have a call so I can explain everything in complete detail.  Questions 1 and 2 are covered in chart 13 of the Investor deck.  Competitors are listed and compared in chart 18.  The valuation number you mentioned is the Valuation Cap, not the value of the company at this time.  If you go here on the Wefunder site (https://help.wefunder.com/foun...)  and search on Valuation Cap, they have put together a very good explanation... better than I could do for sure.  The investor deck is in the DOWNLOAD section of our Wefunder pages.  It is easy to overlook, for sure!  Could we schedule a call?  My calendly link is:calendly.com/justin-lockedbrandsOr just email me with some times that work for you... justin@lockedbrands.com. ​ During the day, or early morning or evenings is fine, I am here to answer your questions.  Justin - Q: Hi. how much is it per share? - A: Kimberly, great question!  But since this is a convertible note, a direct answer is difficult.  Could we schedule a time for a phone call so I can explain?  If so, please propose a few times or use my Calendly link:  calendly.com/justin-lockedbrands - Q: I want to put my investment in the name of my grandchild. How do I do that?